Self-compassion for People with Multiple Sclerosis: an Exploratory Feasibility Study
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Multiple Sclerosis
- Sponsor
- Robert Simpson
- Enrollment
- 45
- Locations
- 1
- Primary Endpoint
- Adherence
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
The goal of this clinical trial is to develop and investigate a compassion-based intervention (Mindful Self-Compassion course) in people with multiple sclerosis. The main objectives are:
- Explore feasibility of trial processes including recruitment, adherence, retention, and follow-up
- Explore experiences of people with multiple sclerosis with the Compassion-based intervention, including perceived effects, barriers and facilitators to participation, suggestions for improvement
- Determine potential effects on stress, anxiety, depression, emotion regulation, illness adjustment, and self-compassion.
Participants will be asked to take part in an 8-week online Mindful Self-Compassion course and report changes in levels of stress, anxiety, depression, self-compassion, adjustment, emotion, and quality of life from pre- to post-intervention and at 3-month follow-up. Additionally, participants will be asked to take part in a semi-structured interview to explore their experiences with the course, perceived effects, and suggestions for improvement.
Investigators
Robert Simpson
Investigator
Unity Health Toronto
Eligibility Criteria
Inclusion Criteria
- •Aged 18 years or older
- •Able to understand spoken and written English
- •Have a neurologist-confirmed diagnosis of multiple sclerosis
- •Willing to take place in an Mindful Self Compassion course
Exclusion Criteria
- •Cognitive impairment (\<26 on the Montreal Cognitive Assessment)
- •Severe active mental health impairment (psychosis, suicidality)
Outcomes
Primary Outcomes
Adherence
Time Frame: 4 months
The investigators will measure the number of participants who completed the mindful self-compassion course.
Recruitment
Time Frame: 4 months
The investigators will measure the number of participants eligible for and recruited to the study.
Retention
Time Frame: 4 months
The investigators will measure the percentage of participants who complete outcome data.
Follow-up rates
Time Frame: 4 months
The investigators will measure the percentage of participants who complete outcome measures pre-intervention, post-intervention, and at 3 months post-intervention.
Secondary Outcomes
- Anxiety(Measured at baseline, 8-week follow-up, and 3-month follow-up.)
- Depression(Measured at baseline, 8-week follow-up, and 3-month follow-up.)
- Stress(Measured at baseline, 8-week follow-up, and 3-month follow-up.)
- Self-compassion(Measured at baseline, 8-week follow-up, and 3-month follow-up.)
- Emotion Regulation(Measured at baseline, 8-week follow-up, and 3-month follow-up.)
- Adjustment(Measured at baseline, 8-week follow-up, and 3-month follow-up.)
- Quality of Life using the Multiple Sclerosis Impact Scale (MSIS-29)(Measured at baseline, 8-week follow-up, and 3-month follow-up.)
- Participant Experiences and Perspectives(Measured at baseline, 8-week follow-up, and 3-month follow-up.)